Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Jungaberle H

15 indexed publications match this author name.

ORCID: 0000-0001-7634-4211
OpenAlex: https://openalex.org/A5137123194

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 12 Safety 8 Clinical Trial 7 Anxiety 6 Randomized Controlled Trial 4 Treatment-Resistant Depression 4 Chronic Pain 3 Addiction 3 End-of-Life Distress 3 Toxicity 2 Adverse Events 2 Mechanism of Action 2

Journals

Neuroscience Applied 2 Psychotherapy and Psychosomatics 1 JAMA Psychiatry 1 The Lancet Psychiatry 1 edoc Publication server (Humboldt University of Berlin) 1 Fortschritte der Neurologie · Psychiatrie 1 European Neuropsychopharmacology 1 Pharmacopsychiatry 1

Publication history

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26 Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-03-17 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trialNeuroscience Applied · 2025-12-31 Compassionate use of psilocybin for treatment-resistant depression in GermanyThe Lancet Psychiatry · 2025-09-22 Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländernedoc Publication server (Humboldt University of Berlin) · 2025-02-11 Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.Unknown journal · 2024-11-30 [Attitudes of Mental Health Experts Towards Psilocybin].Fortschritte der Neurologie · Psychiatrie · 2022-06-19 Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience Applied · 2022-03-06 P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current statusEuropean Neuropsychopharmacology · 2021-11-30 The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.Pharmacopsychiatry · 2021-05-11 Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.Psychopharmacology · 2020-04-30 Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.Frontiers in psychiatry · 2019-12-31 Psychedelic Microdosing: A Subreddit Analysis.Journal of psychoactive drugs · 2019-12-31 Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.Unknown journal · 2017-09-21 [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Unknown journal · 2017-06-30

Author directory